Tetrabenazine is neuroprotective in Huntington's disease mice. - Wikidata - thesis-toulmin - TriplyDB

Tetrabenazine is neuroprotective in Huntington's disease mice.

Tetrabenazine is neuroprotective in Huntington's disease mice.

http://www.wikidata.org/entity/Q33863426

about

Mood disorders in Huntington's disease: from behavior to cellular and molecular mechanisms The importance of integrating basic and clinical research toward the development of new therapies for Huntington disease Mouse models of polyglutamine diseases in therapeutic approaches: review and data table. Part II.BDNF overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 mice Therapeutic approaches to preventing cell death in Huntington disease An automated and quantitative method to evaluate progression of striatal pathology in Huntington's disease transgenic mice.Expanded polyglutamine-binding peptoid as a novel therapeutic agent for treatment of Huntington's disease.Dantrolene is neuroprotective in Huntington's disease transgenic mouse model.Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression.Brain networks in Huntington disease.Huntington's disease: can mice lead the way to treatment?Management of Huntington's disease: role of tetrabenazine.Dopamine imbalance in Huntington's disease: a mechanism for the lack of behavioral flexibility.Neuroprotective effects of psychotropic drugs in Huntington's disease Animal models of Huntington's disease for translation to the clinic: best practices.Preclinical models: needed in translation? A Pro/Con debate.Corticostriatal circuit dysfunction in Huntington's disease: intersection of glutamate, dopamine and calcium.Activational and effort-related aspects of motivation: neural mechanisms and implications for psychopathology.Dopamine depleters in the treatment of hyperkinetic movement disorders.Dysregulation of Corticostriatal Connectivity in Huntington's Disease: A Role for Dopamine Modulation Not All Antidepressants Are Created Equal: Differential Effects of Monoamine Uptake Inhibitors on Effort-Related Choice Behavior.A New VMAT-2 Inhibitor NBI-641449 in the Treatment of Huntington Disease.Revisiting the neuropsychiatry of Huntington's disease.The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion.Dopamine, Effort-Based Choice, and Behavioral Economics: Basic and Translational Research.Caffeine and Selective Adenosine Receptor Antagonists as New Therapeutic Tools for the Motivational Symptoms of Depression.Generation and characterisation of a parkin-Pacrg knockout mouse line and a Pacrg knockout mouse line.

P2860

Q21131050-5EF89768-D78A-42E8-9B15-07FD08B4659B Q22306292-033573EF-5343-4884-BE26-869D10820EE1 Q27005950-26DCE346-A700-47B7-A6C3-D4759998E697 Q34338809-481F8C59-EEEF-4364-ABD5-5A8AB4E28646 Q34411338-134EE829-8E8D-451D-A6FD-C38AB41D9F4F Q35049775-C424C275-5250-48EC-BDBD-BBEA7E52DFFA Q35244160-BD43CC58-D220-49C3-B3E7-B5551FD8A198 Q35605391-96C896A4-1BC9-4A86-AC0A-F3A2E2108F8B Q37362447-D07838FF-24D2-4384-BC95-C48D65FB63CD Q37834193-5ED02F3D-E78E-4CC3-9135-3815F1F5BA9E Q37840353-777B3895-BCCC-412E-9B09-E8431D709F9D Q37863463-06FD2A89-B532-4E0A-AED6-E7BAE12CF8AC Q38121068-7A0C7B92-CBD0-46AC-AA35-01B9A770B4C5 Q38163877-CF08F587-0334-454C-97AB-BA28C3C85180 Q38248687-B24450EE-B2F5-4BD5-9E47-2A527DE8E897 Q38248688-59647650-595D-4FBC-93F6-1BD4A4ED92BF Q38603960-83D0B278-C835-4AF3-AD38-3CF94D3A14B1 Q38836831-F7293C5D-8149-4D5A-BF55-3A1DFBD4F251 Q39000590-B4FC1559-F396-44A3-A30C-9D18BEBBF585 Q39041217-8E397E06-0770-41E5-BFE4-056335ACF4AF Q43096386-24E9C30D-DE96-440D-95E1-10A9C87AD638 Q45288855-4E95795D-9376-4A1F-B0E7-2AA969EA9B96 Q45305909-3C3557A7-C866-4E4A-BD10-3EAEEA41BEAE Q48190081-D5101895-3033-4428-A6FD-BED283FBB62D Q52599712-73E28BF7-910A-4A9B-B58A-D9A26A32D752 Q55132660-9ED2738F-E633-4745-A653-E3C5A7F6263D Q55527707-76066132-6971-4765-A461-40381ABE7411

P2860

Tetrabenazine is neuroprotective in Huntington's disease mice.

http://www.wikidata.org/entity/Q33863426

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Tetrabenazine is neuroprotective in Huntington's disease mice.

@ast

Tetrabenazine is neuroprotective in Huntington's disease mice.

@en

type

label

Tetrabenazine is neuroprotective in Huntington's disease mice.

@ast

Tetrabenazine is neuroprotective in Huntington's disease mice.

@en

prefLabel

Tetrabenazine is neuroprotective in Huntington's disease mice.

@ast

Tetrabenazine is neuroprotective in Huntington's disease mice.

@en

P1433

Q33863426-1C7AB3A0-D73E-4DD7-A1FF-BB1946F20D4D

P1476

Q33863426-29ED87D7-2C5B-410B-9AFA-6D99EA5FE15B

P2093

Q33863426-23151DFD-EB64-46EC-A7AF-029EE13DCEA4

Q33863426-2F4F60BC-36D9-4A50-9762-B982EA41B5DC

Q33863426-72C3E603-FB43-4A7C-8989-9B7882DDC31D

Q33863426-77D0B4B9-59BE-48E9-AC06-9847F7C5F1B5

Q33863426-D59C1C0F-EFD9-4DCE-AFD2-D1932DD2CA58

P2860

Q33863426-020C2ECC-8B1D-4ACF-9CE9-CCCACD8E938B

Q33863426-09492FAD-E36D-4277-8FA1-CD159FA4FADE

Q33863426-0AF56A74-007C-44B5-9230-A5B194AE5FC6

Q33863426-0BDEF801-BD5D-4684-9097-913AE1A9F306

Q33863426-0FD69F50-9619-4587-A0F1-C10F39E734EC

Q33863426-111EB71F-F468-4C0A-97B0-FB6BFD44D65B

Q33863426-1332C71A-4E32-4FFA-9700-A25FC65F6091

Q33863426-19760662-E971-4F92-B9AE-DA66AB985EC0

Q33863426-1BCD1E31-2E7E-47F9-BDA3-E8FD42AF4F63

Q33863426-1CCC2564-0C60-4103-A371-AC98B4A2B7E7

P2888

Q33863426-B423DDDF-C0CB-4C7F-A5E6-55F22371E6C1

P304

Q33863426-55995F98-05B0-4A15-B60E-5511165887EF

P31

Q33863426-2AA06FD3-1CB1-44D4-AD11-FB3DC99DCE47

P356

Q33863426-725DBA10-931E-41B9-92A6-B7C7FC450513

P478

Q33863426-BCBBE018-15B6-494F-9988-908AD0EB3588

P577

Q33863426-9CF25A53-A23B-452B-8B5D-ACB045CE9AF7

P5875

Q33863426-CF48BA80-E3B4-48D3-94B8-3933C2384020

P6179

Q33863426-F54D421B-53A3-4EC4-ACF4-1013D8A590EA

P698

Q33863426-C3045A16-8FA8-4E0C-9BA1-D2D82E4981E3

P921

Q33863426-F6AC5335-4E26-4582-94BF-D8AAC198A704

P932

Q33863426-87CE1785-5947-49B7-BED8-0FFFD17F7F3F

P356

P1433

Molecular Neurodegeneration

P1476

Tetrabenazine is neuroprotective in Huntington's disease mice.

@en

P2093

Hongyu Wang

http://www.w3.org/2001/XMLSchema#string

Ilya Bezprozvanny

http://www.w3.org/2001/XMLSchema#string

Tie-Shan Tang

http://www.w3.org/2001/XMLSchema#string

Xi Chen

http://www.w3.org/2001/XMLSchema#string

Yuemei Li

http://www.w3.org/2001/XMLSchema#string

P2860

Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1

Neuroprotective effects of inositol 1,4,5-trisphosphate receptor C-terminal fragment in a Huntington's disease mouse model

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

Huntingtin: alive and well and working in middle management

The hunt for huntingtin function: interaction partners tell many different stories

Depression: a new animal model sensitive to antidepressant treatments

Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease

Modulatory actions of dopamine on NMDA receptor-mediated responses are reduced in D1A-deficient mutant mice

Dopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: role of D1 receptors and DARPP-32

Polyglutamine-expanded huntingtin promotes sensitization of N-methyl-D-aspartate receptors via post-synaptic density 95.

P2888

P304

18

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1750-1326-5-18

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2010-04-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43344958

http://www.w3.org/2001/XMLSchema#string

P6179

1016943691

http://www.w3.org/2001/XMLSchema#string

P698

20420689

http://www.w3.org/2001/XMLSchema#string

P921

Huntington disease

P932

2873255

http://www.w3.org/2001/XMLSchema#string